Clinical cancer chemoprevention: From the hepatitis B virus (HBV) vaccine to the human papillomavirus (HPV) vaccine

Approximately 2 million new cancer cases are attributed to infectious agents each year worldwide. Vaccines for the hepatitis B virus (HBV), a risk factor of hepatocellular cancer, and human papillomavirus (HPV), a risk factor of cervical cancer, are considered major successes in clinical chemopreven...

Ausführliche Beschreibung

Bibliografische Detailangaben

1. Verfasser:	Horng-Jyh Tsai
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2015-04-01
Schriftenreihe:	Taiwanese Journal of Obstetrics & Gynecology
Schlagworte:	clinical cancer chemoprevention hepatitis B virus (HBV) vaccine human papillomavirus (HPV) vaccine immunization vaccination
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S1028455915000212
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!